Paper Title:
Control Release of Paclitexel-Coated 316L Cardiovascular Stent In Vitro
  Abstract

Now the Cardio vascular restenosis in the clinic is still an unsolved question. The fact is that, if the 316L stent is without coating, it will harm the blood vessel wall and the inflammatory reaction of eye winker. This research is about the Paclitexel-drug coating stent that can be adapted to avoid restenosis. The drug control released by different methods, and also the nano-material releasing after the coating formation are investigated.

  Info
Periodical
Key Engineering Materials (Volumes 288-289)
Edited by
Xingdong Zhang, Junzo Tanaka, Yaoting Yu and Yasuhiko Tabata
Pages
583-586
DOI
10.4028/www.scientific.net/KEM.288-289.583
Citation
H. Dong, X. Y. Li, M. Guo, X. J. Liu, "Control Release of Paclitexel-Coated 316L Cardiovascular Stent In Vitro", Key Engineering Materials, Vols. 288-289, pp. 583-586, 2005
Online since
June 2005
Export
Price
$32.00
Share

In order to see related information, you need to Login.

In order to see related information, you need to Login.

Authors: Wei Wang, Li Bin Zhu, Ji You Gu, Xiang Li Weng, Hai Yan Tan
Abstract:Through the study of the effects of different dosage of additives on the properties of urea formaldehyde resin adhesive prepared at low mole...
147